These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk factor control for coronary artery disease secondary prevention in large randomized trials. Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281 [TBL] [Abstract][Full Text] [Related]
4. The long-term risk of smoking in diabetic patients with stable ischemic heart disease treated with intensive medical therapy and lifestyle modification. Khan AA; Chung MJ; Novak E; Mori Brooks M; Brown DL Eur J Prev Cardiol; 2017 Sep; 24(14):1506-1514. PubMed ID: 28517955 [TBL] [Abstract][Full Text] [Related]
5. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. Ikramuddin S; Korner J; Lee WJ; Thomas AJ; Connett JE; Bantle JP; Leslie DB; Wang Q; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Billington CJ JAMA; 2018 Jan; 319(3):266-278. PubMed ID: 29340678 [TBL] [Abstract][Full Text] [Related]
6. Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial. Damluji AA; Cohen ER; Moscucci M; Myerburg RJ; Cohen MG; Brooks MM; Rich MW; Forman DE Int J Cardiol; 2017 Aug; 241():35-40. PubMed ID: 28314486 [TBL] [Abstract][Full Text] [Related]
7. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease. Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935 [TBL] [Abstract][Full Text] [Related]
8. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study. Wan KS; Moy FM; Mustapha FI; Ismail M; Hairi NN J Diabetes; 2021 Nov; 13(11):915-929. PubMed ID: 34142456 [TBL] [Abstract][Full Text] [Related]
9. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388 [TBL] [Abstract][Full Text] [Related]
10. Effect of baseline glycemic level on long-term cardiovascular outcomes after coronary revascularization therapy in patients with type 2 diabetes mellitus treated with hypoglycemic agents. Ehara N; Morimoto T; Furukawa Y; Shizuta S; Taniguchi R; Nakagawa Y; Hoshino K; Saito N; Doi T; Haruna Y; Ozasa N; Imai Y; Teramukai S; Fukushima M; Kita T; Kimura T Am J Cardiol; 2010 Apr; 105(7):960-6. PubMed ID: 20346313 [TBL] [Abstract][Full Text] [Related]
11. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience. Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856 [TBL] [Abstract][Full Text] [Related]
12. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. Huo X; Spatz ES; Ding Q; Horak P; Zheng X; Masters C; Zhang H; Irwin ML; Yan X; Guan W; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L BMJ Open; 2017 Dec; 7(12):e018302. PubMed ID: 29273661 [TBL] [Abstract][Full Text] [Related]
13. Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine. Vistisen D; Andersen GS; Hansen CS; Hulman A; Henriksen JE; Bech-Nielsen H; Jørgensen ME Circulation; 2016 Mar; 133(11):1058-66. PubMed ID: 26888765 [TBL] [Abstract][Full Text] [Related]
14. Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement. Leiter LA; Cheng AYY; Ekoé JM; Goldenberg RM; Harris SB; Hramiak IM; Khunti K; Lin PJ; Richard JF; Senior PA; Yale JF; Goldin L; Tan MK; Langer A Can J Diabetes; 2019 Aug; 43(6):384-391. PubMed ID: 30554985 [TBL] [Abstract][Full Text] [Related]
15. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB; Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107 [TBL] [Abstract][Full Text] [Related]
16. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. Blicklé JF; Hancu N; Piletic M; Profozic V; Shestakova M; Dain MP; Jacqueminet S; Grimaldi A Diabetes Obes Metab; 2009 Apr; 11(4):379-86. PubMed ID: 19087105 [TBL] [Abstract][Full Text] [Related]
17. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial. Khan AA; Chung MJ; Novak E; Brown DL J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941 [TBL] [Abstract][Full Text] [Related]
18. Quality measure attainment in patients with type 2 diabetes mellitus. Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194 [TBL] [Abstract][Full Text] [Related]
19. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial. Jamil Y; Park DY; Verde LM; Sherwood MW; Tehrani BN; Batchelor WB; Frampton J; Damluji AA; Nanna MG Am J Cardiol; 2024 Mar; 214():66-76. PubMed ID: 38160927 [TBL] [Abstract][Full Text] [Related]
20. Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial. White WB; Jalil F; Cushman WC; Bakris GL; Bergenstal R; Heller SR; Liu Y; Mehta C; Zannad F; Cannon CP J Am Heart Assoc; 2018 Oct; 7(20):e009114. PubMed ID: 30371278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]